<?xml version="1.0" encoding="UTF-8"?><root><date> 09:56:03.54 </date> <title> enzon enzn say drug treat diseas </title> <body> enzon inc say new treatment use investig new drug peg-ada restor function immun system first two child born defici enzym adenosin deaminas the disord know sever combin immunodefici diseas `` bubbl boy diseas bubbl boy diseas rare sever diseas hamper develop immun system It kill victim adulthood child diseas consign live steril environ plastic bubbl avoid infect compani say the studi enzon drug conduct duke univers show two child suffer diseas treat 11 seven month respect free seriou infect time compani say the result publish new england journal medicin the diseas caus miss enzym call adenosin deaminas ada crucial develop immun system enzon say develop technolog coat enzym substanc call polyethylen glycol peg serv disguis enzym reintroduc bodi prevent reject `` mark improv laboratori test immun function occur child along increas number immun cell miss treatment peg-ada begin studi say `` the child activ begin gain weight height befor treatment growth poor comparison normal child age studi conduct doctor michael hershfield rebecca buckley say the peg-ada inject give week victim diseas tradit treat bone marrow transplant donor avail transplant unsuccess compani say other diseas caus miss enzym might also treat introduc peg coat enzym articl note </body></root>